Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma
Publication
, Conference
Voorhees, PM; Gasparetto, C; Osman, K; Richards, K; Ferraro, M; Garcia, R; MacLean, J; Winans, D; Moore, D; Strader, J; Orlowski, RZ; Hurd, DD
Published in: BLOOD
November 19, 2010
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
815 / 816
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Voorhees, P. M., Gasparetto, C., Osman, K., Richards, K., Ferraro, M., Garcia, R., … Hurd, D. D. (2010). Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma. In BLOOD (Vol. 116, pp. 815–816). Orlando, FL: AMER SOC HEMATOLOGY.
Voorhees, Peter M., Cristina Gasparetto, Keren Osman, Kristy Richards, Madlyn Ferraro, Reynaldo Garcia, Jennifer MacLean, et al. “Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma.” In BLOOD, 116:815–16. AMER SOC HEMATOLOGY, 2010.
Voorhees PM, Gasparetto C, Osman K, Richards K, Ferraro M, Garcia R, et al. Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma. In: BLOOD. AMER SOC HEMATOLOGY; 2010. p. 815–6.
Voorhees, Peter M., et al. “Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma.” BLOOD, vol. 116, no. 21, AMER SOC HEMATOLOGY, 2010, pp. 815–16.
Voorhees PM, Gasparetto C, Osman K, Richards K, Ferraro M, Garcia R, MacLean J, Winans D, Moore D, Strader J, Orlowski RZ, Hurd DD. Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma. BLOOD. AMER SOC HEMATOLOGY; 2010. p. 815–816.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
815 / 816
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology